Zhuzhou Qianjin Pharmaceutical Co.,Ltd.’s Net Profit Rose 11.2% in First Quarter of 2023
Listen to the full version

Zhuzhou Qianjin Pharmaceutical Co.,Ltd. (株洲千金药业股份有限公司) (600479.SH) reported a net profit of 56.7 million yuan in the first quarter of 2023, up 11.2% year-on-year.
Meanwhile, the company posted 1 billion yuan in revenue, up 0.8% year-on-year.
At the end of the reporting period, it had 4.5 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 36.5%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR